Russell Investments Group’s Apyx Medical APYX Stock Holding History

Russell Investments Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$96	Buy	+26	New	+$97	﹤0.01%	4153
2022 Q3	–	Sell	-71,383	Closed	-$418K	–	2900
2022 Q2	$418K	Buy	71,383 +33,503	+88%	+$172K	﹤0.01%	2329
2022 Q1	$247K	Sell	37,880 -117,041	-76%	-$1.15M	﹤0.01%	2419
2021 Q4	$1.98M	Buy	154,921 +12,263	+9%	+$172K	﹤0.01%	1807
2021 Q3	$1.97M	Buy	142,658 +13,928	+11%	+$147K	﹤0.01%	1836
2021 Q2	$1.33M	Buy	128,730 +889	+0.7%	+$8.81K	﹤0.01%	2167
2021 Q1	$1.23M	Buy	127,841 +45,114	+55%	+$451K	﹤0.01%	2155
2020 Q4	$594K	Buy	82,727 +44,847	+118%	+$297K	﹤0.01%	2356
2020 Q3	$178K	Buy	+37,880	New	+$188K	﹤0.01%	2808
2020 Q1	–	Sell	-54,166	Closed	-$458K	–	3026
2019 Q4	$458K	Buy	+54,166	New	+$391K	﹤0.01%	2430
2018 Q3	–	Sell	-114,508	Closed	-$498K	–	2945
2018 Q2	$498K	Buy	+114,508	New	+$422K	﹤0.01%	2393

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Russell Investments Group's APYX Position: Q1 2026 in Review

Russell Investments Group opened a new position in Apyx Medical (APYX) in Q1 2026: 26 shares worth $96. The stake represents ﹤0.01% of the portfolio and ranks #4153 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in APYX as recently as Q2 2022.

Russell Investments Group first reported a position in APYX in Q2 2018 and has held it in 11 quarters since. The position peaked at $1.98M in Q4 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

Russell Investments Group held 26 shares of Apyx Medical worth $96 as of Q1 2026.
Apyx Medical was a new Russell Investments Group position in Q1 2026.
Apyx Medical made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #4153 holding.
Russell Investments Group first reported a position in Apyx Medical in Q2 2018 and has held it in 11 quarters since.
Russell Investments Group's Apyx Medical position peaked at $1.98M in Q4 2021.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.